For research updates, follow us on:
Independent institutional research identifying structural risk and asymmetric downside in small and micro-cap equities.
– ZenaTech (NASDAQ: ZENA) has advanced approximately C$28.2 million in cash to Epazz (OTC: EPAZ), controlled by ZenaTech CEO Shaun Passleym, for R&D. – ZENA then purchased these developed assets
Mega Matrix Corp (MPU) entered a letter of intent to acquire 60% of FunVerse (the owner of FlexTV)
Pulse Biosciences (PLSE) is a medical device company with one product, called the CellFX system, which delivers nanosecond
Rego Payment Architectures’ (RPMT) flagship product is app Mazoola, a financial program for families. RPMT’s revenue has been
Greenwich LifeSciences (GLSI) is a pre-revenue biotech that has only one experimental drug in its pipeline, GP2, which
Know Labs (KNW) is a blatant and obvious medical device scam, claiming to be able to non-invasively measure
Sabizabulin’s mechanism of action doesn’t make sense to treat Covid. Veru already had a relationship with the centers
